Purple Biotech Initiates Phase 1b/2 Clinical Trial of CM24 Therapy for Non-Small Cell Lung Cancer & Pancreatic Cancer
Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the initiation of a…
Continue Reading
Purple Biotech Initiates Phase 1b/2 Clinical Trial of CM24 Therapy for Non-Small Cell Lung Cancer & Pancreatic Cancer